ISL
BIIB icon

Ingalls & Snyder LLC’s Biogen BIIB Stock Holding History

Ingalls & Snyder LLC’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-740
Closed -$209K – 474
2021
Q3 		$209K Buy
740
+90
+14% +$29.5K 0.01% 432
2021
Q2 		$225K Sell
650
-70
-10% -$21.2K 0.01% 424
2021
Q1 		$201K Buy
+720
New +$194K 0.01% 414
2020
Q1 		– Sell
-735
Closed -$218K – 408
2019
Q4 		$218K Sell
735
-140
-16% -$38.8K 0.01% 365
2019
Q3 		$204K Sell
875
-5,789
-87% -$1.35M 0.01% 397
2019
Q2 		$1.56M Sell
6,664
-5,381
-45% -$1.24M 0.08% 177
2019
Q1 		$2.85M Buy
12,045
+4,608
+62% +$1.45M 0.14% 127
2018
Q4 		$2.24M Sell
7,437
-303
-4% -$96.7K 0.12% 136
2018
Q3 		$2.73M Sell
7,740
-59
-0.8% -$20.3K 0.12% 141
2018
Q2 		$2.26M Sell
7,799
-390
-5% -$110K 0.11% 139
2018
Q1 		$2.24M Buy
8,189
+1,521
+23% +$472K 0.11% 141
2017
Q4 		$2.12M Buy
6,668
+491
+8% +$158K 0.1% 148
2017
Q3 		$1.93M Buy
6,177
+3
+0% +$888 0.1% 138
2017
Q2 		$1.68M Buy
6,174
+133
+2% +$35.2K 0.09% 146
2017
Q1 		$1.65M Buy
6,041
+3,397
+128% +$960K 0.09% 160
2016
Q4 		$750K Sell
2,644
-97
-4% -$28.8K 0.04% 218
2016
Q3 		$858K Buy
2,741
+36
+1% +$10.7K 0.05% 205
2016
Q2 		$654K Buy
2,705
+625
+30% +$165K 0.04% 226
2016
Q1 		$541K Buy
2,080
+61
+3% +$16.1K 0.03% 221
2015
Q4 		$618K Sell
2,019
-104
-5% -$29.9K 0.04% 214
2015
Q3 		$619K Buy
+2,123
New +$701K 0.04% 206

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Ingalls & Snyder LLC's BIIB Position: Q4 2021 in Review

Ingalls & Snyder LLC sold out of Biogen (BIIB) in Q4 2021, closing a stake of 740 shares — an estimated $209K sold.

Ingalls & Snyder LLC first reported a position in BIIB in Q3 2015 and held it in 21 quarters. The position peaked at $2.85M in Q1 2019. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q4 2021.

  • Ingalls & Snyder LLC reported no remaining Biogen position as of Q4 2021 after selling out during the quarter.
  • Ingalls & Snyder LLC sold 740 Biogen shares in Q4 2021, an estimated $209K.
  • Ingalls & Snyder LLC first reported a position in Biogen in Q3 2015 and held it in 21 quarters.
  • Ingalls & Snyder LLC's Biogen position peaked at $2.85M in Q1 2019.
  • 1,009 funds tracked by Wall St. Rank held Biogen as of Q4 2021.

Based on Ingalls & Snyder LLC's 13F filing for Q4 2021, filed 11 Feb 2022.